The therapeutic community is buzzing with anticipation surrounding retatrutide, a innovative dual GIP and GLP-1 receptor that’s demonstrating significant efficacy in clinical trials for managing obesity. Unlike some available weight loss treatments, retatrutide appears to provide a greater substantial reduction in body weight and improve metaboli